WINDLAS BIOTECH
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Windlas Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.67₹ 6.65
As on Sep 12, 2025, 4:01 PM IST
Windlas Biotech Price Performance
Today's LowToday's High
₹973.40₹1,024.50
₹999.35
52 Weeks' Low52 Weeks' High
₹667.30₹1,197.00
₹999.35
Open Price
₹973.40
Prev. Close
₹992.70
Volume
2,926
Over the last 5 years, the share price of Windlas Biotech has gained 19.70% CAGR. Over the past year, the corresponding return has been 11.57%.
Windlas Biotech’s current P/E of 32.14x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Windlas Biotech Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Windlas Biotech | 0.42 | 4.49 | 7.58 | 12.47 | 11.57 | 61.27 | 19.70 |
| Sun Pharmaceutical Industries | 0.97 | -0.73 | -4.56 | -3.95 | -13.67 | 21.98 | 26.56 |
| Divi's Laboratories | 0.07 | 0.88 | -10.55 | 6.14 | 9.71 | 17.82 | 13.69 |
| Cipla | 1.32 | 3.49 | 4.77 | 8.25 | -5.03 | 13.91 | 16.87 |
| Torrent Pharmaceuticals | -0.56 | -1.88 | 9.19 | 14.98 | 2.90 | 33.17 | 20.55 |
| Dr. Reddy's Laboratories | 3.77 | 7.85 | -3.43 | 19.10 | -1.52 | 15.58 | 8.56 |
| Mankind Pharma | 1.25 | 6.28 | 8.24 | 19.09 | 6.23 | 21.96 | 12.65 |
| Zydus Lifesciences | 3.03 | 9.28 | 6.77 | 17.53 | -6.72 | 40.52 | 23.17 |
| Lupin | 5.05 | 5.10 | 1.03 | 3.96 | -9.07 | 44.90 | 16.11 |
| Abbott India | -0.30 | -3.89 | -1.24 | 4.23 | 4.63 | 19.70 | 13.47 |
| Alkem Laboratories | 1.96 | 5.64 | 12.31 | 14.54 | -14.27 | 19.30 | 13.34 |
| Aurobindo Pharma | 4.78 | 3.43 | -5.26 | -1.14 | -29.86 | 25.70 | 6.59 |
| Glenmark Pharmaceuticals | 3.46 | 3.29 | 29.73 | 49.52 | 21.55 | 75.97 | 34.52 |
| Biocon | 0.26 | 2.78 | 3.50 | 12.23 | -3.13 | 6.33 | -3.24 |
| Laurus Labs | 1.70 | 7.84 | 34.48 | 53.36 | 76.74 | 17.90 | 27.44 |
| GlaxoSmithKline Pharmaceuticals | 0.17 | 7.18 | -16.38 | 3.45 | -3.04 | 24.98 | 9.94 |
| Anthem Biosciences | 0.28 | 11.92 | 13.93 | 13.93 | 13.93 | 4.44 | 2.64 |
| Cohance Lifesciences | 5.60 | 2.61 | -3.08 | -15.81 | -17.91 | 26.94 | 21.87 |
| Ipca Laboratories | -1.62 | -4.55 | -5.03 | -0.24 | -9.78 | 14.50 | 4.09 |
| Gland Pharma | 6.68 | 4.84 | 21.20 | 28.02 | 6.91 | -5.10 | 2.10 |
Over the last one year, Windlas Biotech has gained 11.57% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (9.71%), Cipla (-5.03%). From a 5 year perspective, Windlas Biotech has outperformed peers relative to Sun Pharmaceutical Industries (26.56%) and Divi's Laboratories (13.69%).
Windlas Biotech Financials
Windlas Biotech Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 997.47 | 995.5 |
| 10 | 993.09 | 995.7 |
| 20 | 1,007.27 | 992.98 |
| 50 | 964.25 | 975.19 |
| 100 | 955.01 | 961.28 |
| 200 | 963.9 | 931.54 |
Windlas Biotech Share Holding Pattern
In the latest quarter, Windlas Biotech remained same as its previous close in promoter holding, while DII stake increased to 11.22%, FII holding fell to 1.44%, and public shareholding moved down to 25.01% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Windlas Biotech Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 8,57,651 | 1.39 | 84.83 |
| ICICI Prudential Smallcap Fund | 3,43,133 | 0.4 | 33.94 |
| UTI Healthcare Fund | 1,60,507 | 1.39 | 15.87 |
| Bandhan Small Cap Fund | 51,399 | 0.04 | 5.08 |
| Motilal Oswal BSE Healthcare ETF | 186 | 0.06 | 0.02 |
Windlas Biotech Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 10, 2025, 11:31 PM IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 06, 2025, 7:28 PM IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 01, 2025, 11:53 PM IST | Windlas Biotech - Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 |
| Sep 01, 2025, 6:56 PM IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 01, 2025, 6:52 PM IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About Windlas Biotech
Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company's Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407. Currently Company is involved in the business activities of Manufacture of pulp, paper and paperboard. Company's Total Operating Revenue is Rs. 759.88 Cr. and Equity Capital is Rs. 10.48 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address40/1, Mohabewala Industrial Area, Dehradun Uttarakhand/Uttaranchal 248110
- Contact
Management
- Mr. Vivek DhariwalChairman & Ind.Director
- Mr. Hitesh WindlassManaging Director
- Mr. Manoj Kumar WindlassJoint Managing Director
- Mr. Pawan Kumar SharmaExecutive Director
- Mr. Ashok Kumar WindlassWhole Time Director
- Mrs. Prachi Jain WindlassNon Executive Director
- Mr. Srinivasan VenkataramanIndependent Director
- Mr. Gaurav GulatiIndependent Director
FAQs on Windlas Biotech Share Price
What is the share price of Windlas Biotech?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Windlas Biotech is ₹999.35 as on Sep 12, 2025.
What kind of stock is Windlas Biotech?
The Windlas Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Windlas Biotech?
The market cap of Windlas Biotech is ₹2,094.57 Cr as on Sep 12, 2025.
What are today's High and Low prices of Windlas Biotech?
Today’s highest and lowest price of Windlas Biotech are ₹1,024.50 and ₹973.40.
What are the 52 Week High and 52 Week Low of Windlas Biotech?
The 52-week high/low is the highest and lowest price at which Windlas Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Windlas Biotech is ₹1,197.00 and 52-week low of Windlas Biotech is ₹667.30 as on Sep 12, 2025.
How has the Windlas Biotech performed historically in terms of returns?
The Windlas Biotech has shown returns of 0.67% over the past day, 4.49% for the past month, 7.58% over 3 months, 11.57% over 1 year, 61.27% across 3 years, and 19.7% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Windlas Biotech?
P/E ratio of and PB ratio of Windlas Biotech are 32.14 and 4.44 on Sep 12, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data